Middlemore Clinical Trials

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Hepatitis B1 trial
• Mantle cell lymphoma1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• BeiGene1 trial
• Hoffmann-La Roche1 trial
• Loxo Oncology, Inc.1 trial

Running trials

• Active, not recruiting

  Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

  NCT04662255· Phase 3· Loxo Oncology, Inc.· Source

Closed trials

• Completed

  A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

  NCT04225715· Phase 2· Hoffmann-La Roche· Source

• Completed

  A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

  NCT03734016· Phase 3· BeiGene· Source